Theravance Biopharma, Inc. (TBPH)
18.86
+0.15
(+0.80%)
USD |
NASDAQ |
Dec 30, 16:00
18.86
0.00 (0.00%)
After-Hours: 20:00
Theravance Biopharma Market Cap: 955.68M for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 7.391B |
| Perspective Therapeutics, Inc. | 204.43M |
| Skye Bioscience, Inc. | 22.80M |
| FibroGen, Inc. | 35.24M |
| Myomo, Inc. | 35.86M |
Market Cap Related Metrics
| PE Ratio | 33.53 |
| PS Ratio | 11.84 |
| Price to Book Value | 4.107 |
| Price to Free Cash Flow | 3.905 |
| Price | 18.86 |
| Earnings Yield | 2.98% |
| Normalized PE Ratio | 33.53 |